A carregar...

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer

Since epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in ovarian cancers, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. In this review, we discuss the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Noriyuki Takai, Hisashi Narahara
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Limited 2010-01-01
Colecção:Journal of Oncology
Acesso em linha:http://dx.doi.org/10.1155/2010/458431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!